Toggle navigation
About
About Us
Management Team
Board of Directors
Advisory Board
Partnering
Technology
rhCollagen
3D Bioprinting
Product Pipeline
Collink.3D Bioinks
Collink.3D 50
Collink.3D 50L
Collink.3D 90
Gut-on-a-Chip
Medical Aesthetics
Dermal Fillers
Breast Implants
Vergenix products
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Media Room
Publications
Posters and Presentations
Media Coverage
Videos
Sustainability
Contact
Contact us
Careers
search
Search for:
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events
Email Alerts
Company Info
Overview
Presentations
Management Team
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
SEC Filings
Overview
All SEC Filings
Annual Reports
Filing Type:
View All
144
20-F
424B3
424B5
6-K
8-A12B
CERT
CORRESP
CT ORDER
D
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
F-3/A
F-6
POS AM
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Date
Form
Description
PDF
XBRL
Pages
10/21/16
F-1
Registration statement for securities of certain foreign private issuers
Documents
EX-3.1
EX-3.2
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-21.1
EX-23.1
395
07/27/16
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.1
EX-3.2
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-21.1
392
11/16/15
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
239
11/13/15
DRSLTR
Correspondence Related to Draft Registration Statement
4
07/17/15
UPLOAD
SEC-generated letter
3
07/01/15
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
233
06/30/15
DRSLTR
Correspondence Related to Draft Registration Statement
6
06/22/15
UPLOAD
SEC-generated letter
6
05/26/15
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
216
03/03/15
EFFECT
Notice of Effectiveness
1
Previous
1…
17
18
19
20
21
22
23
24
25
26
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Details
explore
CollPlant Ltd
4 Oppenheimer Street
P.O. Box 4132
Rehovot 7670104, Israel
LinkedIn
Youtube
Twitter
local_phone
+972 73 2325600
local_printshop
+972 73 2325602
mail
info@collplant.com
® 2024 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20